Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AORTIC 2017 /
Access to WHO essential medicines

7th - 10th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.11.17
Views: 1334

Dr Yehoda Martei - University of Pennsylvania, Philadelphia, USA

Dr Martei speaks with ecancer at AORTIC 2017 about access and affordability of medicines on the WHO Essential Medicines List.

Using the list as a guide, she describes how healthcare in Botswana compares to other African healthcare systems, with national essential medicines list providing alternative indicators for care provision.

Dr Martei highlights issues in stocking and procurement of medicines as endemic across global health systems, with cost being a particular concern for care in Botswana.

Looking forward, she describes how data from the Botswana Cancer Registry has been used to track and forecast drug cost and procurement, and to inform cost/benefit analyses around newer targeted drugs.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation